Detailed product reference
Summaries refer to the listed Japanese product. Eligibility, adjustments and full risks depend on its label and strength; a clinician determines individual treatment.
Product overview
A long-acting dihydropyridine calcium-channel blocker. Norvasc conventional and orally disintegrating tablets contain the same active ingredient; administration and packaging differ.
Read source section ↗Mechanism of action
Blocks voltage-dependent calcium entry in vascular smooth muscle, relaxing coronary and peripheral vessels.
Read source section ↗Japanese indications & eligibility
Japanese indications are hypertension and angina. Pediatric hypertension provisions cover children aged six and over.
Read source section ↗Administration & dose differences
Label examples: hypertension 2.5–5 mg once daily, up to 10 mg when needed; angina usually 5 mg daily.
Read source section ↗Adverse effects & key risks
Edema, flushing, headache and dizziness may occur. Important risks include excessive hypotension and liver or blood abnormalities.
Read source section ↗Contraindications & special populations
Contraindicated with ingredient hypersensitivity. Liver impairment, low blood pressure and pregnancy require assessment.
Read source section ↗Drug interactions
Review CYP3A4 modifiers, other antihypertensives, simvastatin and tacrolimus.
Read source section ↗Assessment & monitoring
Track blood pressure, pulse, edema and dizziness; assess laboratory findings when indicated.
Read source section ↗Storage & handling
Store at room temperature in the original packaging. The photo shows a 5 mg blister only.
Read source section ↗Sources & verification
Product checked ·
- PMDA electronic package insert ↗www.pmda.go.jp
Primary source for mechanism, indications, doses and risks; revision: 2026-05.
- Manufacturer information ↗www.viatris-e-channel.com
Official product or related information; professional portals may require identity confirmation.
- Wikipedia: ingredient background ↗en.wikipedia.org
Background reference; Japanese approvals and administration are governed by PMDA sources.
